Onglyza (Saxagliptin) for Diabetes

Overview
Onglyza is a prescription drug approved by the Food and Drug Administration (FDA) to help improve blood glucose control in adults with type 2 diabetes. Onglyza is considered an adjunct treatment to diet and exercise. Onglyza is also referred to by its drug name, Saxagliptin.

Onglyza is a dipeptidyl peptidase 4 (DPP-4) inhibitor. Onglyza is believed to work by lowering blood glucose levels when they are elevated.

How do I take it?
Prescribing information states that Onglyza is generally taken once daily with or without food.

Onglyza comes in tablet form.

Side effects
The FDA-approved label for Onglyza lists common side effects including urinary tract infection, upper respiratory infection, and headache.

Rare but serious side effects listed for Onglyza include pancreatitis and systemic allergic reaction.